Brittany Trang is a health tech reporter at STAT, where she writes the AI Prognosis newsletter. Her reporting focuses on the intersection of healthcare technology, artificial intelligence, and wellness, exploring topics such as digital health, telehealth, and AI platforms. Brittany's work has been featured in RealClearMarkets, RamaOnHealthcare, and STAT News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Brittany Trang's coverage predominantly focuses on the healthcare and pharmaceutical industry, particularly in relation to technology, artificial intelligence, cybersecurity, data breaches, medical research and government regulations. She frequently covers government announcements and press releases related to these topics.
Given her focus on reporting legal policy regulation within the healthcare sector, Brittany would likely be interested in receiving pitches from experts who have insights into regulatory changes impacting the healthcare industry or can provide commentary on how new legislation could affect healthcare technology companies or medical research.
While no specific geographic focus is mentioned for Brittany's articles, she appears to cover international health-related news. This indicates that she may be open to receiving information about global trends and developments in the healthcare and pharmaceutical industries.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Brittany Trang
The AI company's proposals sound responsible but are self-interested, experts say
You're reading the web edition of STAT's AI Prognosis newsletter
You're reading the web edition of STAT's AI Prognosis newsletter Y ou're reading the web edition of STAT's Health Tech newsletter, our guide to how technology is transforming the life sciences.
By: Brittany Trang
Now CEO of billion-dollar AI drug discovery startup Xaira, Tessier-Lavigne says he's learned about trust
You're reading the web edition of STAT's AI Prognosis newsletter
Peyton Greenside, CEO of BigHat Biosciences, gets real about what AI can and can't do SAN MATEO, Calif. — Peyton Greenside, CEO of BigHat Biosciences, has hot takes.
Patient panels offer Stanford Health Care a window into what patients want from AI tools At Stanford University, it's easy to get carried away with technology.
You're reading the web edition of STAT's AI Prognosis newsletter
Congressional Democrats are mounting a fresh effort to end a Medicare experiment to use AI to approve or deny care.
By: Brittany Trang
The VC firm said it hoped to use the Ohio safety-net hospital as a test bed for new technologies
